Biography:
Feng Yan is currently a professor and doctor's supervisor at Department of Clinical Laboratory, the Affiliated Cancer Hospital of Nanjing Medical University. She has long been engaged in research on the mechanisms of malignant tumor development and related biomarkers. She has published 67 papers as first author or corresponding author (51 of which are SCI-indexed), obtained 6 authorized national invention patents, co-authored one English monograph (Elsevier: *Immunosensing for Detection of Protein Biomarkers*, 2017), edited two Chinese monographs, and contributed to one additional Chinese monograph.
Title : tRNA-derived fragment 3?tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer